{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:02:29Z","timestamp":1793739749374,"version":"4.6.1"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"1163","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatocellular adenomas (HCA) are acquired focal liver lesions, that occur mainly in young-to-middle-aged women who are on long-term estrogen-containing contraceptives or young men after prolonged use of anabolic steroids. Furthermore, distinct underlying diseases, such as obesity, metabolic dysfunction-associated steatotic liver disease, glycogen storage disease, etc. are considered risk factors. The 2017 Bordeaux classification, in particular Nault et al, divided HCAs into eight subtypes according to their pheno- and genotypic characteristics. This includes HCAs with hepatocyte-nuclear-factor (HNF1-alpha mutation), HCAs with \u03b2-catenin mutation, and HCAs without either of these genetic mutations, which are further subdivided into HCAs with and without inflammatory cells. HCAs should no longer be classified as purely benign without histologic workup since three of the eight subtypes are considered high-risk lesions, requiring adequate management: malignant transformation of the pure (\u00dfex3-HCA) and mixed inflammatory\/\u03b2-catenin exon 3 (\u00dfex3-IHCA) adenomas, as well as potential bleeding of the sonic hedgehog HCA and pure (\u00dfex7\/8-HCA) and mixed inflammatory\/\u03b2-catenin exon 7\/8 (\u00dfex7\/8-IHCA). Elective surgery is recommended for any HCA in a male, or for any HCA exceeding 5\u2009cm. Although MRI can classify up to 80% of adenomas, if findings are equivocal, biopsy remains the reference standard for adenoma subtype.<\/jats:p>","DOI":"10.1093\/bjr\/tqae180","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T19:34:00Z","timestamp":1725564840000},"page":"1740-1754","source":"Crossref","is-referenced-by-count":27,"title":["Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course"],"prefix":"10.1093","volume":"97","author":[{"given":"Sarah","family":"Poetter-Lang","sequence":"first","affiliation":[{"name":"Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3527-404X","authenticated-orcid":false,"given":"Ahmed","family":"Ba-Ssalamah","sequence":"additional","affiliation":[{"name":"Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Bastati","sequence":"additional","affiliation":[{"name":"Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami A","family":"Ba-Ssalamah","sequence":"additional","affiliation":[{"name":"Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline C","family":"Hodge","sequence":"additional","affiliation":[{"name":"Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, 1090 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Brancatelli","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Palermo, Palermo, 90133 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Paradis","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Beaujon\u2014APHP Nord, Universit\u00e9 Paris Cit\u00e9, Clichy, 92110 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Vilgrain","sequence":"additional","affiliation":[{"name":"Department of Radiology, H\u00f4pital Beaujon\u2014APHP Nord, Universit\u00e9 Paris Cit\u00e9, Clichy, 92110 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"issue":"19","key":"2024102107545612300_tqae180-B1","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3748\/wjg.v13.i19.2649","article-title":"Genotype phenotype classification of hepatocellular adenoma","volume":"13","author":"Bioulac-Sage","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2024102107545612300_tqae180-B2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4132\/jptm.2021.02.27","article-title":"Hepatocellular adenomas: recent updates","volume":"55","author":"Kim","year":"2021","journal-title":"J Pathol Transl Med"},{"issue":"6","key":"2024102107545612300_tqae180-B3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"2024102107545612300_tqae180-B4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2016.11.042","article-title":"Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation","volume":"152","author":"Nault","year":"2017","journal-title":"Gastroenterology"},{"key":"2024102107545612300_tqae180-B5","author":"Shreenath","year":"2023"},{"issue":"2","key":"2024102107545612300_tqae180-B6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/hmg\/ddac197","article-title":"Molecular mechanism underlying impaired hepatic autophagy in glycogen storage disease type Ib","volume":"32","author":"Gautam","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2024102107545612300_tqae180-B7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12020-019-02138-x","article-title":"Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature","volume":"67","author":"Fu","year":"2020","journal-title":"Endocrine"},{"key":"2024102107545612300_tqae180-B8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13000-016-0475-5","article-title":"Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis","volume":"11","author":"Margolskee","year":"2016","journal-title":"Diagn Pathol"},{"key":"2024102107545612300_tqae180-B9","author":"Estrogens and Oral Contraceptives","year":"2012"},{"issue":"6","key":"2024102107545612300_tqae180-B10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1177\/1756283X16663882","article-title":"Hepatocellular adenoma: when and how to treat? Update of current evidence","volume":"9","author":"Thomeer","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"issue":"9","key":"2024102107545612300_tqae180-B11","doi-asserted-by":"crossref","first-page":"100211","DOI":"10.1016\/j.modpat.2023.100211","article-title":"Borderline hepatocellular adenomas: a practical diagnostic approach based on pathologic and molecular features","volume":"36","author":"Pot\u00e9","year":"2023","journal-title":"Mod Pathol"},{"issue":"3","key":"2024102107545612300_tqae180-B12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.21743","article-title":"Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry","volume":"46","author":"Bioulac-Sage","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"2024102107545612300_tqae180-B13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.semdp.2016.12.007","article-title":"Hepatocellular adenoma: classification, variants and clinical relevance","volume":"34","author":"Bioulac-Sage","year":"2017","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"2024102107545612300_tqae180-B14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000268407","article-title":"Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma","volume":"27","author":"van den Esschert","year":"2010","journal-title":"Dig Surg"},{"issue":"4","key":"2024102107545612300_tqae180-B15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ultrasmedbio.2014.11.012","article-title":"Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma","volume":"41","author":"Kong","year":"2015","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"2024102107545612300_tqae180-B16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2214\/AJR.07.2493","article-title":"Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography","volume":"190","author":"Kim","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2024102107545612300_tqae180-B17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2214\/AJR.11.7046","article-title":"Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings","volume":"199","author":"Laumonier","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"2024102107545612300_tqae180-B18","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ultrasmedbio.2020.04.030","article-title":"Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS","volume":"46","author":"Dietrich","year":"2020","journal-title":"Ultrasound Med Biol"},{"issue":"3","key":"2024102107545612300_tqae180-B19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5009\/gnl.2014.8.3.292","article-title":"Clinically useful diagnostic tool of contrast enhanced ultrasonography for focal liver masses: comparison to computed tomography and magnetic resonance imaging","volume":"8","author":"Ryu","year":"2014","journal-title":"Gut Liver"},{"issue":"1","key":"2024102107545612300_tqae180-B20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2214\/AJR.18.19704","article-title":"Liver calcifications and calcified liver masses: pattern recognition approach on CT","volume":"211","author":"Patnana","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2024102107545612300_tqae180-B21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1600-0676.1984.tb00955.x","article-title":"Cholestatic features in focal nodular hyperplasia of the liver","volume":"4","author":"Butron Vila","year":"1984","journal-title":"Liver"},{"issue":"3","key":"2024102107545612300_tqae180-B22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1148\/radiology.214.3.r00mr28861","article-title":"Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients","volume":"214","author":"Ichikawa","year":"2000","journal-title":"Radiology"},{"issue":"1","key":"2024102107545612300_tqae180-B23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11605-018-3917-4","article-title":"Current approaches in the management of hepatic adenomas","volume":"23","author":"Tsilimigras","year":"2019","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"2024102107545612300_tqae180-B24","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00330-020-06726-8","article-title":"Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?","volume":"30","author":"Auer","year":"2020","journal-title":"Eur Radiol"},{"issue":"3","key":"2024102107545612300_tqae180-B25","doi-asserted-by":"crossref","first-page":"e220134","DOI":"10.1148\/rg.220134","article-title":"Hepatocellular adenomas: molecular basis and multimodality imaging update","volume":"43","author":"Tse","year":"2023","journal-title":"Radiographics"},{"issue":"1","key":"2024102107545612300_tqae180-B26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2214\/AJR.22.27989","article-title":"Hepatic adenoma subtypes on hepatobiliary phase of gadoxetic acid-enhanced MRI: systematic review and meta-analysis","volume":"220","author":"Kim","year":"2023","journal-title":"AJR Am J Roentgenol"},{"key":"2024102107545612300_tqae180-B27","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.29279","article-title":"Beta-catenin-mutated hepatocellular adenomas at hepatobiliary phase MRI: a systematic review and meta-analysis","author":"Shen","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"2024102107545612300_tqae180-B28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/liv.14349","article-title":"EASL clinical practice guidelines for the management of occupational liver diseases","volume":"40 Suppl 1","author":"Colombo","year":"2020","journal-title":"Liver Int"},{"issue":"11S","key":"2024102107545612300_tqae180-B29","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1016\/j.jacr.2020.09.005","article-title":"ACR appropriateness criteria(R) liver lesion-initial characterization","volume":"17","author":"Chernyak","year":"2020","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"2024102107545612300_tqae180-B30","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00330-014-3144-7","article-title":"Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience","volume":"24","author":"Grieser","year":"2014","journal-title":"Eur Radiol"},{"issue":"7","key":"2024102107545612300_tqae180-B31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7150\/ijms.17865","article-title":"Diagnostic value of gadoxetic acid-enhanced MR imaging to distinguish HCA and its subtype from FNH: a systematic review","volume":"14","author":"Guo","year":"2017","journal-title":"Int J Med Sci"},{"issue":"4","key":"2024102107545612300_tqae180-B32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.ro.2016.05.016","article-title":"Magnetic resonanance imaging of the liver (including biliary contrast agents)-Part 2: protocols for liver magnetic resonanance imaging and characterization of common focal liver lesions","volume":"51","author":"Agostini","year":"2016","journal-title":"Semin Roentgenol"},{"issue":"1","key":"2024102107545612300_tqae180-B33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13244-022-01223-6","article-title":"Differentiation of hepatocellular adenoma by subtype and hepatocellular carcinoma in non-cirrhotic liver by fractal analysis of perfusion MRI","volume":"13","author":"Michallek","year":"2022","journal-title":"Insights Imaging"},{"issue":"20","key":"2024102107545612300_tqae180-B34","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.3748\/wjg.v25.i20.2442","article-title":"Hepatocellular adenoma: an unsolved diagnostic enigma","volume":"25","author":"Renzulli","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"11","key":"2024102107545612300_tqae180-B35","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1007\/s00261-020-02779-x","article-title":"Quantification of liver function using gadoxetic acid-enhanced MRI","volume":"45","author":"Poetter-Lang","year":"2020","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"2024102107545612300_tqae180-B36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000592","article-title":"Scoping review of clinical practice guidelines on the management of benign liver tumours","volume":"8","author":"Haring","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"issue":"1","key":"2024102107545612300_tqae180-B37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.hpb.2015.07.001","article-title":"PET-avid hepatocellular adenomas: incidental findings associated with HNF1-alpha mutated lesions","volume":"18","author":"Lee","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"6","key":"2024102107545612300_tqae180-B38","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1007\/s00261-021-02968-2","article-title":"18)F-FDG PET\/CT of hepatocellular adenoma subtypes and review of literature","volume":"46","author":"Young","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"27","key":"2024102107545612300_tqae180-B39","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.3748\/wjg.v19.i27.4432","article-title":"Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan","volume":"19","author":"Lim","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2024102107545612300_tqae180-B40","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/jmri.26902","article-title":"Hepatocellular adenomas: understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach","volume":"51","author":"Zulfiqar","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"2024102107545612300_tqae180-B41","doi-asserted-by":"crossref","first-page":"109027","DOI":"10.1016\/j.ejrad.2020.109027","article-title":"Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas","volume":"128","author":"Gregory","year":"2020","journal-title":"Eur J Radiol"},{"issue":"1","key":"2024102107545612300_tqae180-B42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00247-018-4250-5","article-title":"Contrast-enhanced ultrasound in the diagnosis of pediatric focal nodular hyperplasia and hepatic adenoma: interobserver reliability","volume":"49","author":"Fang","year":"2019","journal-title":"Pediatr Radiol"},{"issue":"9","key":"2024102107545612300_tqae180-B43","first-page":"1099","article-title":"[Contrast-enhanced ultrasound for characterisation of focal liver lesions, practical advice]","volume":"53","author":"Frohlich","year":"2015","journal-title":"Z Gastroenterol"},{"key":"2024102107545612300_tqae180-B44","author":"Bethesda","year":"2020"},{"issue":"1","key":"2024102107545612300_tqae180-B45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/modpathol.2013.114","article-title":"Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma","volume":"27","author":"Joseph","year":"2014","journal-title":"Mod Pathol"},{"issue":"1","key":"2024102107545612300_tqae180-B46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1148\/radiol.2015142366","article-title":"Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging","volume":"277","author":"Ba-Ssalamah","year":"2015","journal-title":"Radiology"},{"issue":"1","key":"2024102107545612300_tqae180-B47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1186\/s40064-016-2406-z","article-title":"Hepatocellular adenoma: comparison between real-time contrast-enhanced ultrasound and dynamic computed tomography","volume":"5","author":"Wang","year":"2016","journal-title":"Springerplus"},{"issue":"5","key":"2024102107545612300_tqae180-B48","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s00330-018-5784-5","article-title":"New MRI features improve subtype classification of hepatocellular adenoma","volume":"29","author":"Bise","year":"2019","journal-title":"Eur Radiol"},{"issue":"1","key":"2024102107545612300_tqae180-B49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000268405","article-title":"Malignant transformation of liver adenoma: an analysis of the literature","volume":"27","author":"Farges","year":"2010","journal-title":"Dig Surg"},{"issue":"6","key":"2024102107545612300_tqae180-B50","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1148\/rg.316115527","article-title":"Genetics and imaging of hepatocellular adenomas: 2011 update","volume":"31","author":"Katabathina","year":"2011","journal-title":"Radiographics"},{"issue":"5","key":"2024102107545612300_tqae180-B51","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/SLA.0000000000005108","article-title":"Hepatocellular adenoma risk factors of hemorrhage: size is not the only concern!: single-center retrospective experience of 261 patients","volume":"274","author":"Julien","year":"2021","journal-title":"Ann Surg"},{"issue":"5","key":"2024102107545612300_tqae180-B52","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1007\/s00330-020-07434-z","article-title":"Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked beta-catenin activation in hepatocellular adenoma","volume":"31","author":"Reizine","year":"2021","journal-title":"Eur Radiol"},{"issue":"7","key":"2024102107545612300_tqae180-B53","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1007\/s00330-023-10344-5","article-title":"Sonic hedgehog hepatocellular adenoma: magnetic resonance imaging features and correlation with histology","volume":"34","author":"Ducatel","year":"2023","journal-title":"Eur Radiol"},{"issue":"4","key":"2024102107545612300_tqae180-B54","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2214\/AJR.22.28233","article-title":"Hepatocellular adenoma subtypes based on 2017 classification system: exploratory study of gadoxetate disodium-enhanced MRI features with proposal of a diagnostic algorithm","volume":"220","author":"Tse","year":"2023","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"2024102107545612300_tqae180-B55","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00261-016-0921-6","article-title":"Impact of hepatobiliary phase liver MRI versus contrast-enhanced ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors","volume":"42","author":"Tselikas","year":"2017","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"2024102107545612300_tqae180-B56","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/jmri.26227","article-title":"Intrapatient comparison of the hepatobiliary phase of Gd-BOPTA and Gd-EOB-DTPA in the differentiation of hepatocellular adenoma from focal nodular hyperplasia","volume":"49","author":"Vanhooymissen","year":"2019","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"2024102107545612300_tqae180-B57","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.2214\/AJR.13.11511","article-title":"Hepatocellular carcinoma in the noncirrhotic liver","volume":"203","author":"Gaddikeri","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"2024102107545612300_tqae180-B58","first-page":"151","article-title":"Fibrolamellar hepatocellular carcinoma: current clinical perspectives","volume":"2","author":"Lafaro","year":"2015","journal-title":"J Hepatocell Carcinoma"},{"issue":"3","key":"2024102107545612300_tqae180-B59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0899-7071(97)00117-4","article-title":"Hepatic adenoma and focal nodular hyperplasia: MR findings with superparamagnetic iron oxide-enhanced MRI","volume":"22","author":"Beets-Tan","year":"1998","journal-title":"Clin Imaging"},{"issue":"6","key":"2024102107545612300_tqae180-B60","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/1522-2586(200006)11:6<665::AID-JMRI13>3.0.CO;2-D","article-title":"Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP","volume":"11","author":"Ba-Ssalamah","year":"2000","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"2024102107545612300_tqae180-B61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1148\/radiol.2020191790","article-title":"Long-term evolution of hepatocellular adenomas at MRI follow-up","volume":"295","author":"Vernuccio","year":"2020","journal-title":"Radiology"},{"issue":"2","key":"2024102107545612300_tqae180-B62","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.32734","article-title":"Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation","volume":"77","author":"Demory","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"2024102107545612300_tqae180-B63","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.3346\/jkms.2020.35.e5","article-title":"Development of hepatocellular carcinoma in patients with glycogen storage disease: a single center retrospective study","volume":"35","author":"Jang","year":"2020","journal-title":"J Korean Med Sci"},{"issue":"7","key":"2024102107545612300_tqae180-B64","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/liv.14547","article-title":"New insights in the management of hepatocellular adenoma","volume":"40","author":"Klompenhouwer","year":"2020","journal-title":"Liver Int"},{"issue":"6","key":"2024102107545612300_tqae180-B65","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s11605-020-04724-1","article-title":"Guidelines for the treatment of hepatocellular adenoma in the era of molecular biology: an experience-based surgeons' perspective","volume":"25","author":"Herman","year":"2021","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"2024102107545612300_tqae180-B66","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","article-title":"EASL clinical practice guidelines on the management of benign liver tumours","volume":"65","author":"European Association for the Study of the Liver","year":"2016","journal-title":"J Hepatol"}],"container-title":["British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/advance-article-pdf\/doi\/10.1093\/bjr\/tqae180\/59215140\/tqae180.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/97\/1163\/1740\/59874292\/tqae180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/97\/1163\/1740\/59874292\/tqae180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T03:59:09Z","timestamp":1729483149000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/97\/1163\/1740\/7749868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":66,"journal-issue":{"issue":"1163","published-online":{"date-parts":[[2024,9,5]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bjr\/tqae180","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,9,5]]}}}